Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial (Nature Medicine, (2022), 28, 12, (2504-2511), 10.1038/s41591-022-02102-9)
Orly Vardeny, James C. Fang, Akshay S. Desai, Pardeep S. Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A. de Boer, Adrian F. Hernandez, Carolyn S.P. Lam, Silvio E. Inzucchi, Felipe A. Martinez, Mikhail N. Kosiborod, David DeMets, Eileen O’Meara, Shelley Zieroth, Josep Comin-Colet, Jaroslaw Drozdz, Chern En Chiang, Masafumi Kitakaze, Magnus PeterssonDaniel Lindholm, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon
Research output: Contribution to journal › Comment/debate › peer-review
Fingerprint
Dive into the research topics of 'Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial (Nature Medicine, (2022), 28, 12, (2504-2511), 10.1038/s41591-022-02102-9)'. Together they form a unique fingerprint.